Skip to main content
. 2010 May 10;54(8):3427–3431. doi: 10.1128/AAC.01753-09

TABLE 2.

Systemic adverse events judged by the investigator as related to the study drug in part 1 of the studya

Event No. of occurrences in cohort
Total placebo (n = 10) 250 mg (n = 6) 500 mg (n = 6) 1,000 mg (n = 6) 1,500 mg (n = 6) 2,000 mg (n = 6)
Abdominal pain 1
Nausea 1
Headache 1 1 1
Paresthesia 1
Somnolence 1
Vulvo-vaginal pruritus 1
a

Single doses of CXA-101 or placebo (6 CXA-101, 2 placebo per cohort).